Annual Operating Profit
-$15.14 M
+$3.73 M+19.75%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual operating income is -$15.14 million, with the most recent change of +$3.73 million (+19.75%) on December 1, 2023.
- During the last 3 years, BRTX annual operating profit has fallen by -$12.39 million (-450.03%).
- BRTX annual operating profit is now -631.52% below its all-time high of -$2.07 million, reached on December 31, 2010.
Performance
BRTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$2.29 M
+$181.80 K+7.36%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly operating income is -$2.29 million, with the most recent change of +$181.80 thousand (+7.36%) on September 1, 2024.
- Over the past year, BRTX quarterly operating profit has increased by +$734.10 thousand (+24.30%).
- BRTX quarterly operating profit is now -517.77% below its all-time high of -$370.20 thousand, reached on September 30, 2010.
Performance
BRTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$12.09 M
+$734.10 K+5.73%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM operating income is -$12.09 million, with the most recent change of +$734.10 thousand (+5.73%) on September 1, 2024.
- Over the past year, BRTX TTM operating profit has increased by +$4.42 million (+26.77%).
- BRTX TTM operating profit is now -3164.67% below its all-time high of -$370.20 thousand, reached on September 30, 2010.
Performance
BRTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BRTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.8% | +24.3% | +26.8% |
| 3 y3 years | -450.0% | +43.0% | +54.1% |
| 5 y5 years | -97.9% | +43.0% | +54.1% |
BRTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.5% | at high | +60.4% | at high | +54.1% |
| 5 y | 5-year | -450.0% | +42.5% | -395.4% | +84.8% | -340.2% | +54.1% |
| alltime | all time | -631.5% | +42.5% | -517.8% | +84.8% | -3164.7% | +54.1% |
BioRestorative Therapies Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.29 M(-7.4%) | -$12.09 M(-5.7%) |
| Jun 2024 | - | -$2.47 M(-39.9%) | -$12.82 M(-4.8%) |
| Mar 2024 | - | -$4.11 M(+27.6%) | -$13.47 M(-11.0%) |
| Dec 2023 | -$15.14 M(-19.8%) | -$3.22 M(+6.6%) | -$15.14 M(-8.3%) |
| Sep 2023 | - | -$3.02 M(-3.1%) | -$16.50 M(-8.8%) |
| Jun 2023 | - | -$3.12 M(-46.1%) | -$18.09 M(-7.7%) |
| Mar 2023 | - | -$5.78 M(+26.0%) | -$19.61 M(+3.9%) |
| Dec 2022 | -$18.86 M(-28.3%) | -$4.59 M(-0.5%) | -$18.86 M(+3.2%) |
| Sep 2022 | - | -$4.61 M(-0.4%) | -$18.28 M(+5.3%) |
| Jun 2022 | - | -$4.63 M(-8.1%) | -$17.36 M(+6.6%) |
| Mar 2022 | - | -$5.04 M(+25.6%) | -$16.29 M(-38.1%) |
| Dec 2021 | -$26.31 M(+855.9%) | -$4.01 M(+8.7%) | -$26.31 M(+13.6%) |
| Sep 2021 | - | -$3.69 M(+3.8%) | -$23.15 M(+15.3%) |
| Jun 2021 | - | -$3.56 M(-76.4%) | -$20.07 M(+18.2%) |
| Mar 2021 | - | -$15.05 M(+1661.8%) | -$16.98 M(+518.5%) |
| Dec 2020 | -$2.75 M(-67.4%) | -$854.50 K(+40.0%) | -$2.75 M(-32.2%) |
| Sep 2020 | - | -$610.30 K(+32.2%) | -$4.05 M(-23.0%) |
| Jun 2020 | - | -$461.60 K(-43.6%) | -$5.26 M(-24.1%) |
| Mar 2020 | - | -$819.00 K(-62.0%) | -$6.92 M(-17.9%) |
| Dec 2019 | -$8.43 M(+10.3%) | -$2.16 M(+18.5%) | -$8.43 M(-0.3%) |
| Sep 2019 | - | -$1.82 M(-14.6%) | -$8.45 M(+8.1%) |
| Jun 2019 | - | -$2.13 M(-8.6%) | -$7.82 M(+1.0%) |
| Mar 2019 | - | -$2.33 M(+6.9%) | -$7.75 M(+1.3%) |
| Dec 2018 | -$7.65 M(-8.7%) | -$2.18 M(+83.2%) | -$7.65 M(+8.6%) |
| Sep 2018 | - | -$1.19 M(-42.0%) | -$7.04 M(-7.3%) |
| Jun 2018 | - | -$2.05 M(-8.1%) | -$7.60 M(-6.4%) |
| Mar 2018 | - | -$2.23 M(+41.9%) | -$8.12 M(-3.1%) |
| Dec 2017 | -$8.37 M | -$1.57 M(-9.8%) | -$8.37 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$1.74 M(-32.1%) | -$8.66 M(+0.3%) |
| Jun 2017 | - | -$2.57 M(+3.2%) | -$8.63 M(+5.2%) |
| Mar 2017 | - | -$2.49 M(+33.9%) | -$8.21 M(+5.4%) |
| Dec 2016 | -$7.79 M(+8.6%) | -$1.86 M(+8.4%) | -$7.79 M(-10.7%) |
| Sep 2016 | - | -$1.72 M(-20.0%) | -$8.72 M(+2.7%) |
| Jun 2016 | - | -$2.14 M(+3.7%) | -$8.49 M(+11.6%) |
| Mar 2016 | - | -$2.07 M(-26.0%) | -$7.61 M(+6.2%) |
| Dec 2015 | -$7.17 M(+45.7%) | -$2.79 M(+87.4%) | -$7.17 M(+25.9%) |
| Sep 2015 | - | -$1.49 M(+18.0%) | -$5.70 M(+11.6%) |
| Jun 2015 | - | -$1.26 M(-22.3%) | -$5.10 M(-0.4%) |
| Mar 2015 | - | -$1.63 M(+23.5%) | -$5.12 M(+4.0%) |
| Dec 2014 | -$4.92 M(+3.6%) | -$1.32 M(+46.9%) | -$4.92 M(+2.2%) |
| Sep 2014 | - | -$896.00 K(-30.1%) | -$4.82 M(-4.6%) |
| Jun 2014 | - | -$1.28 M(-10.3%) | -$5.05 M(+3.4%) |
| Mar 2014 | - | -$1.43 M(+18.1%) | -$4.88 M(+2.7%) |
| Dec 2013 | -$4.75 M(-14.7%) | -$1.21 M(+7.2%) | -$4.75 M(-9.4%) |
| Sep 2013 | - | -$1.13 M(+1.4%) | -$5.25 M(-1.4%) |
| Jun 2013 | - | -$1.11 M(-14.3%) | -$5.32 M(-4.1%) |
| Mar 2013 | - | -$1.30 M(-23.7%) | -$5.55 M(-0.4%) |
| Dec 2012 | -$5.57 M(+56.9%) | -$1.70 M(+41.4%) | -$5.57 M(+23.5%) |
| Sep 2012 | - | -$1.21 M(-10.0%) | -$4.51 M(+8.5%) |
| Jun 2012 | - | -$1.34 M(+1.1%) | -$4.16 M(+7.8%) |
| Mar 2012 | - | -$1.32 M(+105.9%) | -$3.86 M(+8.6%) |
| Dec 2011 | -$3.55 M(+71.7%) | -$643.20 K(-24.6%) | -$3.55 M(-13.1%) |
| Sep 2011 | - | -$853.00 K(-17.8%) | -$4.09 M(+13.4%) |
| Jun 2011 | - | -$1.04 M(+2.0%) | -$3.60 M(+40.5%) |
| Mar 2011 | - | -$1.02 M(-13.5%) | -$2.56 M(+65.8%) |
| Dec 2010 | -$2.07 M | -$1.18 M(+217.8%) | -$1.55 M(+317.8%) |
| Sep 2010 | - | -$370.20 K | -$370.20 K |
FAQ
- What is BioRestorative Therapies annual operating income?
- What is the all time high annual operating profit for BioRestorative Therapies?
- What is BioRestorative Therapies annual operating profit year-on-year change?
- What is BioRestorative Therapies quarterly operating income?
- What is the all time high quarterly operating profit for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly operating profit year-on-year change?
- What is BioRestorative Therapies TTM operating income?
- What is the all time high TTM operating profit for BioRestorative Therapies?
- What is BioRestorative Therapies TTM operating profit year-on-year change?
What is BioRestorative Therapies annual operating income?
The current annual operating profit of BRTX is -$15.14 M
What is the all time high annual operating profit for BioRestorative Therapies?
BioRestorative Therapies all-time high annual operating income is -$2.07 M
What is BioRestorative Therapies annual operating profit year-on-year change?
Over the past year, BRTX annual operating income has changed by +$3.73 M (+19.75%)
What is BioRestorative Therapies quarterly operating income?
The current quarterly operating profit of BRTX is -$2.29 M
What is the all time high quarterly operating profit for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly operating income is -$370.20 K
What is BioRestorative Therapies quarterly operating profit year-on-year change?
Over the past year, BRTX quarterly operating income has changed by +$734.10 K (+24.30%)
What is BioRestorative Therapies TTM operating income?
The current TTM operating profit of BRTX is -$12.09 M
What is the all time high TTM operating profit for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM operating income is -$370.20 K
What is BioRestorative Therapies TTM operating profit year-on-year change?
Over the past year, BRTX TTM operating income has changed by +$4.42 M (+26.77%)